Accelerate Diagnostics Inc (AXDX)

22.50
0.25 1.10
NASDAQ : Health Care
Prev Close 22.25
Open 22.05
Day Low/High 21.90 / 22.85
52 Wk Low/High 10.29 / 29.43
Volume 289.37K
Avg Volume 329.20K
Exchange NASDAQ
Shares Outstanding 55.30M
Market Cap 1.17B
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Notable Thursday Option Activity: AXDX, SHAK, SGMS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Accelerate Diagnostics Inc , where a total volume of 20,566 contracts has been traded thus far today, a contract volume which is representative of approximately 2.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 833.3% of AXDX's average daily trading volume over the past month, of 246,790 shares.

Accelerate Diagnostics Announces Sizeable Release Of Data At ASM Microbe 2017

Ten Poster Presentations; Four Industry & Science Presentations; Two Clinical Adopter Sessions

Notable Thursday Option Activity: AXDX, PFPT, JONE

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc , where a total of 38,374 contracts have traded so far, representing approximately 3.8 million underlying shares. That amounts to about 1882.7% of AXDX's average daily trading volume over the past month of 203,820 shares.

AXDX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 03/31/2017 settlement date, and Accelerate Diagnostics Inc is one of the most shorted stocks of the Russell 3000, based on 41.96 "days to cover" versus the median component at 4.66. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Accelerate Diagnostics Receives FDA Marketing Authorization For The Accelerate Pheno™ System And Accelerate PhenoTest™ BC Kit

First fully automated solution permitted by the FDA for quantitative antibiotic susceptibility testing directly from patient samples

AXDX: Insiders vs. Shorts

AXDX: Insiders vs. Shorts

The most recent short interest data was recently released for the 12/15/2016 settlement date, and Accelerate Diagnostics Inc is one of the most shorted stocks of the Russell 3000, based on 40.79 "days to cover" versus the median component at 4.36. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

4 Breakout Stocks to Watch

4 Breakout Stocks to Watch

These four stocks are looking strong technically, either breaking out or approaching breakout levels.

AXDX September 16th Options Begin Trading

AXDX September 16th Options Begin Trading

Investors in Accelerate Diagnostics Inc saw new options begin trading today, for the September 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AXDX options chain for the new September 16th contracts and identified one put and one call contract of particular interest.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

AXDX: Insiders vs. Shorts

AXDX: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Accelerate Diagnostics Inc is one of the most shorted stocks of the Russell 3000, based on 21.25 "days to cover" versus the median component at 6.29. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Accelerate Diagnostics (AXDX) Is Weak On High Volume Today

Accelerate Diagnostics (AXDX) Is Weak On High Volume Today

Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a weak on high relative volume candidate

Noteworthy Wednesday Option Activity: AXDX, MTZ, VHC

Noteworthy Wednesday Option Activity: AXDX, MTZ, VHC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Accelerate Diagnostics Inc , where a total volume of 2,533 contracts has been traded thus far today, a contract volume which is representative of approximately 253,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 118.7% of AXDX's average daily trading volume over the past month, of 213,440 shares.